RxDoctor Payments Data

Bryan Schneider, MD

Medical Oncology · Ann Arbor, MINPI 1811073786

Payments from drug & device makers

$80,903in general payments, 2019–2025

Across 43 payments — averaging $1881.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$35K
  • F. Hoffmann-la Roche AG$31K
  • Incyte Corporation$15K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.3$35,097
F. Hoffmann-la Roche AG11$31,166
Incyte Corporation29$14,640

How this compares

$80,903 in reported general payments places this provider in the 55th percentile of 170 medical oncology providers in Michigan.

See all medical oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$26,365
Medicare patients
83
Services billed
227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TagrissoOsimertinib Mesylate28$470,046
EliquisApixaban30$21,422
Ondansetron OdtOndansetron14$723
Prochlorperazine Maleate49$700
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$245
Levothyroxine Sodium25$187
Minocycline Hcl11$176
Omeprazole11$174

Paid to pharmacies, not to this prescriber.

Other medical oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →